Note 2 - Summary of Significant Accounting Policies (Q3) (Tables)

9 Months Ended

12 Months Ended

Sep. 30, 2020

Dec. 31, 2019

Summary of Significant Accounting Policies

Schedule of Revenue by Major Customers by Reporting Segments

The following table presents our revenue by customer, on a proportional basis, for the three and nine months ended September 30, 2020 and 2019.

	Three Months Ended									Nine Months Ended
	September 30,									September 30,
Customer	2020			2019			Variance			2020			2019			Variance
Department of Defense		100.0	%		90.0	%		10.0	%		81.2	%		60.2	%		-21.0	%
Incuron		0.0	%		10.0	%		(10.0	)%		18.8	%		39.8	%		-21.0	%
Total		100.0	%		100.0	%		—	%		100.0	%		100.0	%		—	%

The following table presents our revenue by customer, on a proportional basis, for the periods indicated:

	Years ended December 31,
	2019			2018			Variance
U.S. Department of Defense		64.5	%		46.3	%		18.2	%
Incuron, Inc		35.5	%		53.7	%		(18.2	)%
		100.0	%		100.0	%		—	%

Schedule of Accumulated Other Comprehensive Income (Loss)

The following table presents the changes in accumulated other comprehensive loss for the .

	Gains and losses on foreign exchange translations
Beginning balance	$	(568,030	)
Other comprehensive income (loss) before reclassifications		(76,992	)
Amounts reclassified from accumulated other comprehensive loss		—
Ending balance	$	(645,022	)

The following table presents the changes in accumulated other comprehensive loss for the year ended December 31, 

	Gains and losses on foreign exchange translations
Beginning balance	$	(611,370	)
Other comprehensive income (loss) before reclassifications		43,340
Ending balance	$	(568,030	)

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

The Company has excluded the following securities from the calculation of diluted net loss per share because all such securities were antidilutive for the periods presented. Additionally, there were no dilutive securities outstanding as of September 30, 2020.

	As of September 30,
Common Equivalent Securities	2020		2019
Warrants		974,090		327,253
Options		76,879		136,289
Total		1,050,969		463,542

The Company has excluded the following securities from the calculation of diluted net loss per share because all such securities were antidilutive for the periods presented:

	As of December 31,
Common Equivalent Securities	2019		2018
Warrants		327,253		528,054
Options		136,105		160,076
Total		463,358		688,130